The Valley Desk

NCT03580356 · Interventional trial

A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.

Overall registry status Completed

Phase 3

Conditions Chronic Spontaneous Urticaria

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov